172 related articles for article (PubMed ID: 32275456)
1. Formulation of lyophilized oily-core poly-Ɛ-caprolactone nanocapsules to improve oral bioavailability of Olmesartan Medoxomil.
Khattab WM; Zein El-Dein EE; El-Gizawy SA
Drug Dev Ind Pharm; 2020 May; 46(5):795-805. PubMed ID: 32275456
[No Abstract] [Full Text] [Related]
2. Development of olmesartan medoxomil optimized nanosuspension using the Box-Behnken design to improve oral bioavailability.
Nagaraj K; Narendar D; Kishan V
Drug Dev Ind Pharm; 2017 Jul; 43(7):1186-1196. PubMed ID: 28271908
[TBL] [Abstract][Full Text] [Related]
3. Fabrication of Nanosuspension Directly Loaded Fast-Dissolving Films for Enhanced Oral Bioavailability of Olmesartan Medoxomil: In Vitro Characterization and Pharmacokinetic Evaluation in Healthy Human Volunteers.
Alsofany JM; Hamza MY; Abdelbary AA
AAPS PharmSciTech; 2018 Jul; 19(5):2118-2132. PubMed ID: 29700766
[TBL] [Abstract][Full Text] [Related]
4. Design and development of a self-microemulsifying drug delivery system of olmesartan medoxomil for enhanced bioavailability.
Komesli Y; Burak Ozkaya A; Ugur Ergur B; Kirilmaz L; Karasulu E
Drug Dev Ind Pharm; 2019 Aug; 45(8):1292-1305. PubMed ID: 30986085
[TBL] [Abstract][Full Text] [Related]
5. Development of olmesartan medoxomil lipid-based nanoparticles and nanosuspension: preparation, characterization and comparative pharmacokinetic evaluation.
B A; D N; Veerabrahma K
Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):126-137. PubMed ID: 28290712
[TBL] [Abstract][Full Text] [Related]
6. Solid lipid nanoparticles as vesicles for oral delivery of olmesartan medoxomil: formulation, optimization and in vivo evaluation.
Nooli M; Chella N; Kulhari H; Shastri NR; Sistla R
Drug Dev Ind Pharm; 2017 Apr; 43(4):611-617. PubMed ID: 28005442
[TBL] [Abstract][Full Text] [Related]
7. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
[TBL] [Abstract][Full Text] [Related]
8. Formulation, optimization, and in vitro-in vivo evaluation of olmesartan medoxomil nanocrystals.
Jain S; Patel K; Arora S; Reddy VA; Dora CP
Drug Deliv Transl Res; 2017 Apr; 7(2):292-303. PubMed ID: 28116656
[TBL] [Abstract][Full Text] [Related]
9. In Vitro and In Vivo Evaluation of Olmesartan Medoxomil Microcrysta ls and Nanocrystals: Preparation, Characterization, and Pharmacokinet ic Comparison in Beagle Dogs.
Chai R; Gao H; Ma Z; Guo M; Fu Q; Liu H; He Z
Curr Drug Deliv; 2019; 16(6):500-510. PubMed ID: 31244438
[TBL] [Abstract][Full Text] [Related]
10. Nanoemulsion strategy for olmesartan medoxomil improves oral absorption and extended antihypertensive activity in hypertensive rats.
Gorain B; Choudhury H; Kundu A; Sarkar L; Karmakar S; Jaisankar P; Pal TK
Colloids Surf B Biointerfaces; 2014 Mar; 115():286-94. PubMed ID: 24388859
[TBL] [Abstract][Full Text] [Related]
11. Solid lipid nanoparticles as an efficient drug delivery system of olmesartan medoxomil for the treatment of hypertension.
Pandya NT; Jani P; Vanza J; Tandel H
Colloids Surf B Biointerfaces; 2018 May; 165():37-44. PubMed ID: 29453084
[TBL] [Abstract][Full Text] [Related]
12. Comparative biodistribution and safety profiling of olmesartan medoxomil oil-in-water oral nanoemulsion.
Gorain B; Choudhury H; Tekade RK; Karan S; Jaisankar P; Pal TK
Regul Toxicol Pharmacol; 2016 Dec; 82():20-31. PubMed ID: 27815174
[TBL] [Abstract][Full Text] [Related]
13. Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation.
Yousaf AM; Kim DW; Oh YK; Yong CS; Kim JO; Choi HG
Int J Nanomedicine; 2015; 10():1819-30. PubMed ID: 25784807
[TBL] [Abstract][Full Text] [Related]
14. Nanostructured lipid carriers of olmesartan medoxomil with enhanced oral bioavailability.
Kaithwas V; Dora CP; Kushwah V; Jain S
Colloids Surf B Biointerfaces; 2017 Jun; 154():10-20. PubMed ID: 28284054
[TBL] [Abstract][Full Text] [Related]
15. Design, optimization and evaluation of poly-ε-caprolactone (PCL) based polymeric nanoparticles for oral delivery of lopinavir.
Ravi PR; Vats R; Dalal V; Gadekar N; N A
Drug Dev Ind Pharm; 2015 Jan; 41(1):131-40. PubMed ID: 24180260
[TBL] [Abstract][Full Text] [Related]
16. Tailoring of PEGylated bilosomes for promoting the transdermal delivery of olmesartan medoxomil: in-vitro characterization, ex-vivo permeation and in-vivo assessment.
Albash R; El-Nabarawi MA; Refai H; Abdelbary AA
Int J Nanomedicine; 2019; 14():6555-6574. PubMed ID: 31616143
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability Enhancement of Olmesartan Medoxomil Using Hot-Melt Extrusion: In-Silico, In-Vitro, and In-Vivo Evaluation.
Jadhav P; Gokarna V; Deshpande V; Vavia P
AAPS PharmSciTech; 2020 Sep; 21(7):254. PubMed ID: 32888102
[TBL] [Abstract][Full Text] [Related]
18. Trazodone Loaded Lipid Core Poly (ε-caprolactone) Nanocapsules: Development, Characterization and in Vivo Antidepressant Effect Evaluation.
Elhesaisy N; Swidan S
Sci Rep; 2020 Feb; 10(1):1964. PubMed ID: 32029776
[TBL] [Abstract][Full Text] [Related]
19. Nanoemulsion improves the oral bioavailability of baicalin in rats: in vitro and in vivo evaluation.
Zhao L; Wei Y; Huang Y; He B; Zhou Y; Fu J
Int J Nanomedicine; 2013; 8():3769-79. PubMed ID: 24124365
[TBL] [Abstract][Full Text] [Related]
20. Systematic Development of Sertraline Loaded Solid Lipid Nanoparticle (SLN) by Emulsification-Ultrasonication Method and Pharmacokinetic Study in Sprague-Dawley Rats.
Rahman MA; Harwansh RK; Iqbal Z
Pharm Nanotechnol; 2019; 7(2):162-176. PubMed ID: 30919786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
